HROW
Harrow Health Inc
Price:  
29.37 
USD
Volume:  
978,751.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HROW Stock Forecast & Price Target

HROW Stock Price Forecast

The average stock forecast for Harrow Health Inc (HROW) in the next 12 months is 64.26 USD. This price target corresponds to an upside of 118.79%. The range of stock forecasts for HROW is 45.45 - 92.40 USD. Based on the ratings of 15 analysts, the consensus recommendation for HROW is BUY.
Target Low Average Median High
Price (USD) 45.45 64.26 61.20 92.40
Upside 54.75% 118.79% 108.38% 214.61%

Recommendation Trends

The latest consensus rating for HROW is "BUY". This is the average recommendation of 15 analysts: 0 strong sell, 0 sell, 1 hold, 8 buy, 6 strong buy. In the previous period, 15 analysts also majorly recommmended "BUY" for HROW.

HROW Financial Stock Forecast

Revenue This Year
356.74M
31.01%
from 272.30M
Revenue Next Year
541.14M
51.69%
from 356.74M
EPS This Year
-0.16
19.99%
from -0.14
EPS Next Year
2.31
-1,501.55%
from -0.16